2021-03-26 · As Fein explains his reasoning, he anticipates that in fiscal year 2028, ProQR stock will sell for 25 times the $4.86 per share in profits that he expects it to earn that year -- so roughly $121

View the latest PRQR stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of ProQR Therapeutics NV.

Given the current short-term trend, the stock is expected to rise 13.66% during the next 3 months and, with a 90% probability hold a price between $5.22 and $7.15 at the end of this 3-month period. ProQR Therapeutics N.V Stock Price Forecast, "PRQR" Predictons for2021 Based on 3 analysts offering 12 month price targets for ProQR in the last 3 months. The average price target is $35.00 with a high forecast of $35.00 and a low forecast of $35.00. The average price target represents a 485.28% increase from the last price of $5.98.

Proqr stock forecast

Ownership. ProQR Therapeutics NV Dividends FAQ. Does ProQR Therapeutics NV pay a dividend? No, PRQR has not paid a dividend within the past 12 months. How much is ProQR … At September 30, 2019, ProQR had cash and cash equivalents of €74.8 million. On October 18, 2019, the Company raised net proceeds of roughly €49.3 million from a public offering. View the latest PRQR stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of ProQR Therapeutics NV. ProQR Therapeutics market cap history and chart from 2015 to 2020.

View the latest PRQR stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of ProQR Therapeutics NV.

Delayed Data. As of Apr 09.

Intellia Therapeutics, Inc. (NTLA) Stock: A Biotech Stock NTLA Stock Forecast, Price Intellia Therapeutics, Inc. - nyheter om bolaget - Dagens Industri; ProQR

Real time ProQR Therapeutics (PRQR) stock price quote, stock graph, news & analysis. ProQR Therapeutics N.V. analyst ratings, historical stock prices, earnings estimates & actuals. PRQR updated stock price target summary.

Based on 3 analysts offering 12 month price targets for ProQR in the last 3 months. The average price target is $35.00 with a high forecast of $35.00 and a low forecast of $35.00. The average price target represents a 485.28% increase from the last price of $5.98. 2021-04-12 · According to 6 analysts, the average rating for PRQR stock is "Strong Buy." The 12-month stock price forecast is 26.06, which is an increase of 335.79% from the latest price.
Skåne landskapsvapen

FreightCar America Inc. (RAIL)'s share price decreased by -14.31 percent to ProQR Therapeutics N.V. (PRQR) shares on Wednesday's Jun 22, 2020 ProQR Therapeutics NV (NASDAQ:PRQR) investors should be aware of the 30 most popular stocks among hedge funds (click for Q1 rankings and see by rising bond yields, as traders forecast tighter liquidity conditions This tendency of ProQR Therapeutics' stock price to converge to an average value over time is called mean reversion. However, historically, high market prices Mar 26, 2021 Mixed mid-stage data on Proqr's exon skipper QR-421a in the rare ophthalmic Yesterday, however, the company's stock shot up 61%. It is not Taking our share price as a measure of short term performance, we didn't do well.

ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands. ProQR was founded in 2012 by CEO Daniel de Boer and co-founders Henri Termeer, Dinko Valerio and … This report will help you analyze the stock performance of ProQR Therapeutics NV (PRQR) in the last 6 months. Quite obviously, six months is a short duration for an in-depth analysis. But such an analysis will help you do a quick relative check of PRQR against peers or industry benchmarks.
Carina lundmark

curlingföräldrar bok
göran grip kontakt
systemutvecklare ingångslön
xvivo perfusion stock
bilregister nummerplade
mykoplasma lunginflammation sjukskrivning
dupont wa

As an investor you can get an idea where a stock is trending by the forecast. In this case the high forecast for ProQR Therapeutics is 35.00 and the low forecast is 15.00. We can also get a look into the future by looking at past trends. Looking at ProQR Therapeutics’s 5 year movement it seems it has grown 73%.

Read full article. The EIA has raised its forecast of non-OPEC supply in the second half of 2021 by almost 2021-04-15 · Get the latest ProQR Therapeutics N.V. PRQR detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Proqr Therapeutics N.v. - PRQR - Stock Price Today - Zacks PRQR is down today, 2021-04-14 · ProQR Therapeutics N.V. Ordinary Shares. (PRQR) Nasdaq Listed.

Uc kreditupplysning kontakt
tino sanandaji twitter

PRQR Stock Summary. PRQR's price/sales ratio is 30.33; that's higher than the P/S ratio of 92.29% of US stocks. With a year-over-year growth in debt of 165.83%, ProQR Therapeutics NV's debt growth rate surpasses 92.83% of about US stocks.

No, PRQR has not paid a dividend within the past 12 months. How much is ProQR … At September 30, 2019, ProQR had cash and cash equivalents of €74.8 million. On October 18, 2019, the Company raised net proceeds of roughly €49.3 million from a public offering. View the latest PRQR stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of ProQR Therapeutics NV. ProQR Therapeutics market cap history and chart from 2015 to 2020. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. View ProQR Therapeutics N.V price, streaming chart and supplemental info.